These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 34550859)
1. Nanovaccine: an emerging strategy. Das A; Ali N Expert Rev Vaccines; 2021 Oct; 20(10):1273-1290. PubMed ID: 34550859 [TBL] [Abstract][Full Text] [Related]
2. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases. Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651 [TBL] [Abstract][Full Text] [Related]
3. An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria. Chen L; Kang Z; Shen J; Zhao R; Miao Y; Zhang L; Zheng Z; Zhang Z; Liu N; Wang C; Fang H; Zhou J; Wang Y; Liu Z; Yang Y; Chen Q Sci Bull (Beijing); 2024 Aug; 69(16):2565-2579. PubMed ID: 38918142 [TBL] [Abstract][Full Text] [Related]
4. Immunological basis for enhanced immunity of nanoparticle vaccines. Kelly HG; Kent SJ; Wheatley AK Expert Rev Vaccines; 2019 Mar; 18(3):269-280. PubMed ID: 30707635 [TBL] [Abstract][Full Text] [Related]
5. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen. Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155 [TBL] [Abstract][Full Text] [Related]
6. Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection. Xu F; Yuan Y; Wang Y; Yin Q Biomed Pharmacother; 2023 Feb; 158():114117. PubMed ID: 36528914 [TBL] [Abstract][Full Text] [Related]
7. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance. Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804 [TBL] [Abstract][Full Text] [Related]
8. Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges. Ahmad MZ; Ahmad J; Haque A; Alasmary MY; Abdel-Wahab BA; Akhter S Expert Rev Vaccines; 2020 Nov; 19(11):1053-1071. PubMed ID: 33315512 [No Abstract] [Full Text] [Related]
9. A Glance on Nanovaccine: A Potential Approach for Disease Prevention. Garg A; Agrawal R; Chopra H; Singh T; Chaudhary R; Tankara A Curr Pharm Biotechnol; 2024; 25(11):1406-1418. PubMed ID: 37861010 [TBL] [Abstract][Full Text] [Related]
10. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections. Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250 [TBL] [Abstract][Full Text] [Related]
11. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes. Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549 [TBL] [Abstract][Full Text] [Related]
12. Polymeric nanostructure vaccines: applications and challenges. Simón-Vázquez R; Peleteiro M; González-Fernández Á Expert Opin Drug Deliv; 2020 Jul; 17(7):1007-1023. PubMed ID: 32476491 [TBL] [Abstract][Full Text] [Related]
13. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density. Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389 [TBL] [Abstract][Full Text] [Related]
14. Self-adjuvanting cancer nanovaccines. Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176 [TBL] [Abstract][Full Text] [Related]
15. Nanovaccines: A game changing approach in the fight against infectious diseases. Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148 [TBL] [Abstract][Full Text] [Related]
16. Nasal and pulmonary vaccine delivery using particulate carriers. Jia Y; Krishnan L; Omri A Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104 [TBL] [Abstract][Full Text] [Related]